Auto-inoculation of a Wart in Multiple Viral Warts
Sponsor
Pak Emirates Military Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04947332
Collaborator
(none)
80
1
1
12.1
6.6
Study Details
Study Description
Brief Summary
This study is being conducted to see effectiveness of auto-inoculation of a wart in multiple viral warts. Patients with recurrent, multiple warts of all types, are being recruited for the study. A wart is excised, minced and then inoculated in a subcutaneous pocket made on the volar aspect of forearm. Patients are to be reviewed after every 4 weeks to note any reduction in number warts.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
A single arm, Phase 1, Clinical Study
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
80 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
A single arm studyA single arm study
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effectiveness of Auto-inoculation of a Wart in Multiple Viral Warts, in Tertiary Care Hospital : A Single Arm Study
Actual Study Start Date
:
Feb 8, 2021
Anticipated Primary Completion Date
:
Jan 31, 2022
Anticipated Study Completion Date
:
Feb 10, 2022
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Other: Auto-inoculation recipients Auto-inoculation of wart to be performed |
Procedure: Auto-inoculation
A wart will be excised from the body, minced and will be inoculated in a subcutaneous pocket on forearm.
|
Outcome Measures
Primary Outcome Measures
- Complete Clearance of Warts [12 weeks]
All the warts on any part of the body are cleared
- Incomlete Clearance of Warts [12 weeks]
No or size of warts are reduced
- Non Responders [12 weeks]
If no change or increased no of warts
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
Individuals having 5 or warts
-
Individuals having any types of warts
Exclusion Criteria:
- Individuals using any other treatment for warts
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Pak Emirates Military Hospital | Rawalpindi | Punjab | Pakistan |
Sponsors and Collaborators
- Pak Emirates Military Hospital
Investigators
- Study Director: Nadia Iftikhar, MBBS, FCPS, Head of Department
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Muhammad Waseem Shahid,
Resident Dermatology,
Pak Emirates Military Hospital
ClinicalTrials.gov Identifier:
NCT04947332
Other Study ID Numbers:
- A/28/EC/230/2021
First Posted:
Jul 1, 2021
Last Update Posted:
Jan 13, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Muhammad Waseem Shahid,
Resident Dermatology,
Pak Emirates Military Hospital
Additional relevant MeSH terms: